» Articles » PMID: 28286590

Guidelines for Outpatient Cancer Care by Community Pharmacists

Overview
Specialty Pharmacology
Date 2017 Mar 14
PMID 28286590
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Roles of Community Pharmacists in Cancer Management.

Egbewande O, Abdulwasiu M, Yusuf R, Durojaye A, Ashimiyu-Abdulsalam Z Innov Pharm. 2023; 13(3).

PMID: 36627904 PMC: 9815873. DOI: 10.24926/iip.v13i3.4946.


An Integrated Model to Improve Medication Reconciliation in Oncology: Prospective Interventional Study.

Passardi A, Serra P, Donati C, Fiori F, Prati S, Vespignani R J Med Internet Res. 2021; 23(12):e31321.

PMID: 34932001 PMC: 8726040. DOI: 10.2196/31321.


Oncology pharmacist contributions to treatment with oral anticancer agents in a Japanese community pharmacy setting.

Yokoyama S, Yajima S, Shimauchi A, Sakai C, Yamashita S, Noguchi Y Can Pharm J (Ott). 2018; 151(6):377-382.

PMID: 30559912 PMC: 6293393. DOI: 10.1177/1715163518802865.


Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer.

Yokoyama S, Yajima S, Sakai C, Yamashita S, Noguchi Y, Ino Y Can Pharm J (Ott). 2017; 150(6):362-365.

PMID: 29123595 PMC: 5661674. DOI: 10.1177/1715163517732088.


Primary care of cancer patients: A pharmacy student's perspective.

Warsame L Can Pharm J (Ott). 2017; 150(6):351-352.

PMID: 29123591 PMC: 5661680. DOI: 10.1177/1715163517734237.

References
1.
Haynes R, Ackloo E, Sahota N, McDONALD H, Yao X . Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008; (2):CD000011. DOI: 10.1002/14651858.CD000011.pub3. View

2.
Jeon J, White R, Hunt R, Cassano-Piche A, Easty A . Optimizing the design of preprinted orders for ambulatory chemotherapy: combining oncology, human factors, and graphic design. J Oncol Pract. 2012; 8(2):97-102. PMC: 3457836. DOI: 10.1200/JOP.2011.000346. View

3.
Abbott R, Edwards S, Whelan M, Edwards J, Dranitsaris G . Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada. J Oncol Pharm Pract. 2013; 20(1):29-39. DOI: 10.1177/1078155213504975. View

4.
Griffin M, Gilbert R, Broadfield L, Easty A, Trbovich P . ReCAP: Comparison of Independent Error Checks for Oral Versus Intravenous Chemotherapy. J Oncol Pract. 2015; 12(2):168-9. DOI: 10.1200/JOP.2015.005892. View